SLC22A12 Gene Hypouricemia renal type 1 Genetic Test
Components
Price: 4400.0 AED
Sample Condition
Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery
3 to 4 Weeks
Method
NGS Technology
Test Type
Hepatology Nephrology Endocrinology Disorders
Doctor
General Physician
Test Department
Genetics
Pre Test Information
Clinical History of Patient who is going for SLC22A12 Gene Hypouricemia, renal type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC22A12 Gene Hypouricemia, renal type 1 NGS Genetic DNA Test gene SLC22A12
Test Details
SLC22A12 gene hypouricemia, renal type 1 is a genetic disorder characterized by the inability of the kidneys to reabsorb uric acid, resulting in low levels of uric acid in the blood. This condition is caused by mutations in the SLC22A12 gene, which codes for a protein involved in the reabsorption of uric acid in the kidneys.
NGS (Next Generation Sequencing) genetic testing is a type of genetic test that uses high-throughput sequencing technologies to analyze multiple genes simultaneously. It allows for the rapid and cost-effective analysis of large amounts of genetic data. To diagnose SLC22A12 gene hypouricemia, renal type 1, an NGS genetic test can be performed. This test involves sequencing the SLC22A12 gene to identify any mutations or variations that may be present. The results of the test can help confirm the diagnosis and guide treatment decisions.
Genetic testing for SLC22A12 gene hypouricemia, renal type 1 can be particularly beneficial for individuals with a family history of the condition or those who exhibit symptoms such as low levels of uric acid in the blood and recurrent kidney stones. It can also be used for carrier testing in individuals with a family history of the condition who are planning to have children.
It is important to note that genetic testing for SLC22A12 gene hypouricemia, renal type 1 should be performed and interpreted by a qualified healthcare professional or genetic counselor. They can provide appropriate genetic counseling and help individuals understand the implications of the test results.
Test Name | SLC22A12 Gene Hypouricemia renal type 1 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Hepatology Nephrology Endocrinology Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for SLC22A12 Gene Hypouricemia, renal type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC22A12 Gene Hypouricemia, renal type 1 NGS Genetic DNA Test gene SLC22A12 |
Test Details |
SLC22A12 gene hypouricemia, renal type 1 is a genetic disorder characterized by the inability of the kidneys to reabsorb uric acid, resulting in low levels of uric acid in the blood. This condition is caused by mutations in the SLC22A12 gene, which codes for a protein involved in the reabsorption of uric acid in the kidneys. NGS (Next Generation Sequencing) genetic testing is a type of genetic test that uses high-throughput sequencing technologies to analyze multiple genes simultaneously. It allows for the rapid and cost-effective analysis of large amounts of genetic data. To diagnose SLC22A12 gene hypouricemia, renal type 1, an NGS genetic test can be performed. This test involves sequencing the SLC22A12 gene to identify any mutations or variations that may be present. The results of the test can help confirm the diagnosis and guide treatment decisions. Genetic testing for SLC22A12 gene hypouricemia, renal type 1 can be particularly beneficial for individuals with a family history of the condition or those who exhibit symptoms such as low levels of uric acid in the blood and recurrent kidney stones. It can also be used for carrier testing in individuals with a family history of the condition who are planning to have children. It is important to note that genetic testing for SLC22A12 gene hypouricemia, renal type 1 should be performed and interpreted by a qualified healthcare professional or genetic counselor. They can provide appropriate genetic counseling and help individuals understand the implications of the test results. |